Skip to content

5-MeO-DMT: all studies

Page 94 of 112: studies 931 to 940 of 1,115, newest first. Back to the 5-MeO-DMT overview

Research

Delta 9-tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons.

Neuroscience January 24, 2008 K Sano, K Mishima, E Koushi et al.

Delta(9)-tetrahydrocannabinol (THC) has been reported to induce catalepsy-like immobilization, but the mechanism underlying this effect remains unclear. In the present study, in order to fully understand the neural circuits involved, we determined the brain sites involved in the immobilization effect in rats. THC dose-dependently induced catalepsy-like immobilization. THC-induced catalepsy-like...

A general approach to the screening and confirmation of tryptamines and phenethylamines by mass spectral fragmentation.

Talanta January 15, 2008 Bo-Hong Chen, Ju-Tsung Liu, Wen-Xiong Chen et al. 32 citations

Certain characteristic fragmentations of tryptamines (indoleethylamine) and phenethylamines are described. Based on the GC-EI/MS, LC-ESI/MS and MALDI/TOFMS, the mass fragmentations of 13 standard compounds, including alpha-methyltryptamine (AMT), N,N-dimethyltryptamine (DMT), 5-methoxy-alpha-methyltryptamine (5-MeO-AMT), N,N-diethyltryptamine (DET), N,N-dipropyltryptamine (DPT),...

Les effets de l’ayahuasca sur le système nerveux central: étude comportementale

Phytothérapie December 1, 2007 Laís M. S. de Lima, S. M. Ferreira, A. -a. L. Ávila et al. 28 citations

Un échantillon de la boisson ayahuasca contenant les alcaloïdes harmalol, harmol, harmane et N,N-diméthyltryptamine a été évalué dans les tests de nage forcée et d'open-field. Dans le test de nage forcée, les doses ont diminué le temps d'immobilité d'une manière inversement proportionnelle à la dose. Des doses de 2,5 mg/kg et de 10 mg/kg d'ayahuasca ont diminué aussi l'activité locomotrice et...

Daytime Ayahuasca administration modulates REM and slow-wave sleep in healthy volunteers

Psychopharmacology November 20, 2007 Manel J. Barbanoj, Jordi Riba, S. Clos et al. 74 citations

ObjectivesAyahuasca is a traditional South American psychoactive beverage and the central sacrament of Brazilian-based religious groups, with followers in Europe and the United States. The tea contains the psychedelic indole N,N-dimethyltryptamine (DMT) and beta-carboline alkaloids with monoamine oxidase-inhibiting properties that render DMT orally active. DMT interacts with serotonergic...

DOI: 10.1007/s00213-007-0963-0 (opens in new tab) Full text (opens in new tab) Ayahuasca Sleep system call Slow-wave sleep Behavioral sensitization +3

Psilocybin-induced stimulus control in the rat.

Pharmacology, Biochemistry, and Behavior October 1, 2007 Jerrold C Winter, K C Rice, D J Amorosi et al. 73 citations

Although psilocybin has been trained in the rat as a discriminative stimulus, little is known of the pharmacological receptors essential for stimulus control. In the present investigation rats were trained with psilocybin and tests were then conducted employing a series of other hallucinogens and presumed antagonists. An intermediate degree of antagonism of psilocybin was observed following...

NMR spectral assignments of a new chlorotryptamine alkaloid and its analogues from Acacia confusa.

Magnetic resonance in chemistry : MRC April 2007 Malcolm S Buchanan, Anthony R Carroll, David Pass et al.

A new chlorotryptamine alkaloid, N-chloromethyl-N,N-dimethyltryptamine, was isolated from a methanol extract of the Chinese shrub Acacia confusa Merr., together with its known hallucinogenic analogues, N-methyltryptamine, N,N-dimethyltryptamine and N,N-dimethyltryptamine-N-oxide. The new compound was an artefact of the isolation conditions. The complete (1)H and (13)C NMR assignments for these...

The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain.

European Journal of Pharmacology March 22, 2007 Fumiko Nagai, Ryouichi Nonaka, Kanako Satoh Hisashi Kamimura 277 citations

We developed a reproducible, simple, and small-scale method for determining the re-uptake and release of monoamines (dopamine, serotonin (5-HT) and norepinephrine) using rat brain synaptosomes. These assays were then applied to study the effects of different kinds of non-medically used psychoactive drugs on monoamine re-uptake and release. The phenethylamine derivatives, 4-fluoroamphetamine,...

DOI: 10.1016/j.ejphar.2006.11.075 (opens in new tab) Full text (opens in new tab) Serotonin Neurotransmission neurotransmitters Monoamines Dopamine +24

In Vitro Screening of Psychoactive Drugs by [35S]GTP.GAMMA.S Binding in Rat Brain Membranes

Biological and Pharmaceutical Bulletin 2007 Ryouichi Nonaka, Fumiko Nagai, Akio Ogata et al. 31 citations

We constructed a reproducible, simple, and small-scale determination method of the psychoactive drugs that acted directly on the monoamine receptor by measuring the activation of [(35)S]guanosine-5'-O-(3-thio)-triphosphate binding to guanine nucleotide-binding proteins (G proteins). This method can simultaneously measure the effects of three monoamines, namely dopamine (DA), serotonin (5-HT),...

DOI: 10.1248/bpb.30.2328 (opens in new tab) Serotonin Phenethylamines Monoamine neurotransmitter Tryptamines +5

Analysis of hallucinogenic constituents in Amanita mushrooms circulated in Japan.

Forensic Science International December 20, 2006 Kenji Tsujikawa, Hiroyuki Mohri, Kenji Kuwayama et al. 51 citations

The constituents of seven mushrooms sold as Amanita muscaria or Amanita pantherina (five A. muscaria and two A. pantherina) and four "extracts purported to contain A. muscaria" products that are currently circulated in Japan were determined. All mushroom samples were identified as A. muscaria or A. pantherina by macroscopic and microscopic observation. The dissociative constituents, ibotenic...

DOI: 10.1016/j.forsciint.2006.01.004 (opens in new tab) Full text (opens in new tab) Mushroom chemistry Psychoactive substances Product adulteration Amanita mushrooms

DESIGNER DRUGS AS A CAUSE OF HOMICIDE

Addiction October 10, 2006 Toshihiko Matsumoto, Takayuki Okada 29 citations

'Foxy' is a widely used street name for a hallucinogenic drug containing the tryptamine derivative 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT). The US Drug Enforcement Administration classified 5-MeO-DIPT as a Schedule I substance in 2004 [1]; the Japanese Ministry of Health, Labour and Welfare has also restricted this substance since April 2005, according to the Narcotics and...

DOI: 10.1111/j.1360-0443.2006.01573.x (opens in new tab) Psilocybin Designer drug Hallucinogen Euphoriant +1